Home

Tvp20 05 omslag kijk verder

Keywords register: antipsychotics

Short report

50th anniversary issue 2008, suppl.2

D. Denys, L. de Haan

25 years antipsychotics: back to the future?, 105 - 109

Review article

2020/3

G. de Kuijper, L. Ramerman, J. Jonker, P.J. Hoekstra

Dilemmas in discontinuation of antipsychotic drug use in people with intellectual disabilities, 203 - 212

Review article

2019/10

S.K. Spoelstra, L. Visser, H. Knegtering

Cariprazine for acute and maintenance treatment of schizophrenia, 702 - 709

New research

2017/6

E. Deboosere, J. Steyaert, M. Danckaerts

Trends in antipsychotics use by Belgian children and adolescents between 2005 and 2014, 329 - 338

Review article

2016/9

T. Sabbe, J. Detraux, M. De Hert

Prolactin, antipsychotics and breast cancer: is there a connection?, 641 - 649

Case report

2016/4

TH. van Oeffelt, E.J.D. Prinsen

Treatment-resistant psychosis due to interaction between ritonavir and olanzapine: case report and literature review, 309 - 313

New research

2015/3

M. Morrens, G. Dom

Comparison between the regions of Belgium with regard to the amounts of antipsychotics prescribed during the period 2004-2012: a national survey, 161 - 170

Short report

2015/11

C.H. Vinkers, I.E. Sommer

Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands, 830 - 834

Short report

2015/2 themanummer Bewegingsstoornissen

P.R. Bakker, J. van Os, P.N. van Harten

The genetics of antipsychotic-related movement disorders, 114 - 119

Review article

2014/4

C.W. Slotema, J.D. Blom, I.E.C. Sommer

Treatment strategies for auditory verbal hallucinations, 247 - 256

Case report

2014/4

K. Buts, J. Van Hecke

Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry, 273 - 276

Case report

2014/2

M. Grandiek, A.D. Ramlal, J.D. Blom

Mitigated presentation of the neuroleptic malignant syndrome, 114 - 117

Essay

2014/12

S. Kapitein, J. Wieland

The new draft law on care and coercion. Concerning the use and the reduction of antipsychotics without a valid indication in people with intellectual disabilities, 807 - 815

Short report

2013/6

P.G.W.M. Wuisman, M.G.F. Wuisman-Frerker, M.M.B. van Pelt-Halders

The need to monitor risk factors relating to patients on antipsychotics, 439 - 445

Case report

2013/5

J. Harlaar, I.L. Gelderblom, A. van der Sijde, D. Bastiaansen

An adolescent with autism and a somatic high-risk profile receiving treatment with antipsychotics refuses blood tests, 375 - 379

New research

2012/10

A.J. Ouwehand, B.M. Mollema-schelwald, H. Knegtering

The relationship between antipsychotic-induced hyperprolactinemia and menstrual disorders in women with schizophrenia; a systematic review, 861 - 868

Review article

2011/2

G. Faber, A.R. van Gool, H.G.O.M. Smid, D. Wiersma, R.J. van den Bosch

Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?, 107 - 117

Review article

2011/2

H. Knegtering, H. Oolders, M.A. Ruijsink, A.E.G.M. van der Moolen

Depot antipsychotics in the year 2011 , 95 - 105

Review article

2010/5

W.A. Overbeek, M.A.M. de Vroede, B.E. Lahuis, M.H.J. Hillegers, E.R. de Graeff-Meeder

Antipsychotics and metabolic abnormalities in children and adolescents: a review of the literature and some recommendations, 311 - 320

Case report

2010/1

M.H. de Jong, M.L.J.M. Eussen, A.R. van Gool

Antipsychotic agents and stimulants: a judicious combination? , 57 - 61

Case report

2009/1

M. Klein Hofmeijer-Sevink, Z.J. van Eijk, R. van der Zwaard

Acquired stuttering in a psychotic patient , 53 - 57

Review article

2008/9

W. Cahn, D. Ramlal, R. Bruggeman , L. de Haan, F.E. Scheepers, M.M. van Soest, J. Assies, C.J. Slooff

Prevention and treatment of somatic complications arising from the use of antipsychotics , 579 - 591

Review article

2008/10

A.M.J.W. Scheepers-Hoeks, S.J.W. Wessels-Basten, M.J.W.T. Scherders, B. Bravenboer, A.J.M. Loonen, R.T. Kleppe, R.J.E. Grouls

Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview, 645 - 654

Short report

2005/4

T.H. Lange, W. van den Brink, P.J.J. Hanneman

The effects of antipsychotics on patients with a dual diagnosis of schizophrenia and substance abuse. An opinion poll among experts , 253 - 257

Review article

2005/4

T.H. Lange, W. van den Brink, P.J.J. Hanneman

Effectiveness of antipsychotics in patients suffering from both schizophrenia and substance abuse: a literature review , 219 - 228